Vetrivel P student at IEOR, IIT Bombay, presented their research paper titled Verticals at Risk: Diagnosing Process Gaps in Dr. Reddy's Global Competitiveness via the IPO Framework at the International Conference 2026 on Innovation and Entrepreneurship for Deep-Tech Startups: Role of Entrepreneurial Universities, hosted by Adelaide University from 22nd May, 2026.
The paper applies the Input–Process–Output (IPO) framework, integrated with an Asset–Process–Performance (APP)lens, to diagnose internal process gaps in Dr. Reddy's Laboratories (DRL) — a leading Indian pharmaceutical Emerging-market Multinational Enterprise (EMNE) — that constrain its global competitiveness against incumbents such as Pfizer and biosimilar peers including Sandoz and Teva. Through a mixed-method comparative case design combining a VRIO analysis, a Critical Business Process (CBP) map, fishbone diagnosis, and financial benchmarking using Bloomberg data from 2014 to 2025, the study surfaces three key findings: a Process Synchronisation Gap caused by siloed digitalisation between modernised front-end functions and legacy back-end HR and Finance systems; a Speed-to-Market Lag in biosimilar launches relative to global peers; and a Human–Digital Mismatch limiting the impact of DRL's digital health platforms. The authors propose direct integration of HR and Finance into the firm's OpsNext digital platform — through embedded e-HRM and predictive financial analytics — as a strategic pathway to lift DRL's Trade Competitiveness Index (TCI) in biologics and specialty medicine.
The conference provided an opportunity to engage with international researchers, faculty, and industry practitioners working at the intersection of deep-tech innovation, entrepreneurial universities, and emerging-market multinationals, and to discuss the broader policy and managerial implications for India's pharmaceutical sector.